Neurovascular Disorder Clinical Trial
Official title:
Picture This: A Randomized Controlled Pilot Study Investigating Adherence to Blood Pressure Diaries With Personalized Visuals
NCT number | NCT06189378 |
Other study ID # | 1249/2023 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 7, 2023 |
Est. completion date | October 29, 2023 |
Verified date | January 2024 |
Source | Medical University of Vienna |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This trial randomizes patients with a neurovascular diagnosis to a type of blood pressure diary for secondary stroke prevention (conventional blood pressure diary or blood pressure diary including patient-provided images). Outcomes include adherence and patient-reported outcomes.
Status | Completed |
Enrollment | 20 |
Est. completion date | October 29, 2023 |
Est. primary completion date | October 29, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - diagnosis of TIA or stroke (ischemic or hemorrhagic) upon admission. Exclusion Criteria: - Modified Rankin Scale score of =4 at inclusion - Inability to provide informed consent - Pre-existing legal guardianship. |
Country | Name | City | State |
---|---|---|---|
Austria | Medical University of Vienna | Vienna |
Lead Sponsor | Collaborator |
---|---|
Medical University of Vienna |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Exploratory endpoints | Exploratory endpoints evolved around patients' perspectives on blood pressure diaries as assessed by an empirical survey (13 questions in each group) conceived for this study. Possible answers were Likert-type scales, yes/no or open commentaries. | 28 days | |
Primary | Adherence | The primary endpoint was adherence to blood pressure diaries defined as the number of complete blood pressure measurements (maximum of two per day) divided by the maximum number of measures over the study period (28 days, resulting in a maximum total of 56 measurements). Complete entries were defined as diary entries stating date, time and systolic as well as diastolic blood pressure. | 28 days | |
Secondary | Blood pressure | Mean raw values of systolic and diastolic blood pressure | 28 days | |
Secondary | Precision of documentation of blood pressure | The proportion of documented values ending with "0" or "5" served to assess the extent of rounding (i.e. the precision of documentation) | 28 days | |
Secondary | Patient Global Impression of Change Scale | The Patient Global Impression of Change Scale is a self-report rating scale of 1 item on a Likert scale (maximum 7, higher score is better) and 1 item on a scale from 0-10 (higher score is worse). It was applied to assess patient satisfaction. | 28 days | |
Secondary | 36-Item Short Form Health Survey | The 36-Item Short Form Health Survey is a self-report survey of items on a Likert Scale in 8 domains. It is designed to assess quality of life. The maximum amount of points is 100. More points are better. | 28 days | |
Secondary | Hospital Anxiety and Depression Scale | The Hospital Anxiety and Depression Scale is a self-report rating scale of 14 items on a Likert scale. It is designed to measure anxiety and depression (7 items for each subscale). The maximum amount of points in each subscale is 21. More points are worse. | 28 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04888221 -
Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement
|
Phase 3 | |
Recruiting |
NCT04865718 -
Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow
|
||
Recruiting |
NCT04568161 -
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
|
N/A | |
Not yet recruiting |
NCT04537611 -
Deoxyhemoglobin Concentration Changes and Cerebral Perfusion Imaging
|
N/A |